180 Life Sciences Corp (ATNF)
2.25
-0.03
(-1.32%)
USD |
NASDAQ |
Nov 22, 16:00
2.36
+0.11
(+4.89%)
After-Hours: 20:00
180 Life Sciences Free Cash Flow: -2.690M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.690M |
| June 30, 2024 | -4.242M |
| March 31, 2024 | -8.086M |
| December 31, 2023 | -10.92M |
| September 30, 2023 | -11.69M |
| June 30, 2023 | -13.51M |
| March 31, 2023 | -13.92M |
| December 31, 2022 | -12.13M |
| Date | Value |
|---|---|
| September 30, 2022 | -14.23M |
| June 30, 2022 | -14.63M |
| March 31, 2022 | -15.11M |
| December 31, 2021 | -19.37M |
| September 30, 2021 | -17.56M |
| June 30, 2021 | -13.61M |
| March 31, 2021 | -9.793M |
| December 31, 2020 | -3.872M |
Free Cash Flow Range, Past 5 Years
-19.37M
Minimum
Dec 2021
-2.690M
Maximum
Sep 2024
-11.59M
Average
-12.82M
Median
Free Cash Flow Benchmarks
| Seelos Therapeutics Inc | -13.27M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.2237M |
| Cash from Financing (Quarterly) | -0.4761M |
| Free Cash Flow Per Share (Quarterly) | -0.2281 |
| Free Cash Flow Yield | -155.6% |